NDC codes

FDA NDC Directory
Product NDC (as listed)72162-2558Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72162-2558Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72162-2558-172162255801100 TABLET in 1 BOTTLE (72162-2558-1)Marketed from Nov 4, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Repaglinide
Generic name (nonproprietary)
repaglinide
Active ingredients
Repaglinide — 1 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 203820
Marketing start
Listing expires
Other FDA classes
Potassium Channel Antagonists (Mechanism)
Identifiers
Product ID 72162-2558_481210ad-ee08-453c-b79f-27f4a8777d94SPL ID 481210ad-ee08-453c-b79f-27f4a8777d94SPL set ID 6ae28683-28cc-408e-90f9-6a3dddfc668dRxCUI 200256UNII 668Z8C33LU
Pharmacologic class
Glinide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162255801 followed by a unit qualifier and the quantity

Package 72162-2558-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 203820

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203820
ProductStrengthForm · routeLabelerProduct NDC
RepaglinideRepaglinide 1 mg/1TabletOralAmerican Health Packaging60687-560
RepaglinideRepaglinide 2 mg/1TabletOralAurobindo Pharma Limited65862-672
RepaglinideRepaglinide .5 mg/1TabletOralAurobindo Pharma Limited65862-670
RepaglinideRepaglinide 1 mg/1TabletOralAurobindo Pharma Limited65862-671
RepaglinideRepaglinide .5 mg/1TabletOralBryant Ranch Prepack63629-4866
RepaglinideRepaglinide 2 mg/1TabletOralRising Pharma Holdings, Inc.57237-159
RepaglinideRepaglinide .5 mg/1TabletOralRising Pharma Holdings, Inc.57237-157
RepaglinideRepaglinide 1 mg/1TabletOralRising Pharma Holdings, Inc.57237-158

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in